SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-001336
Filing Date
2021-09-21
Accepted
2021-09-21 16:05:22
Documents
12
Period of Report
2021-09-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 e620954_8k-summit.htm   iXBRL 8-K 21131
  Complete submission text file 0001193805-21-001336.txt   194482

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA smmt-20210921.xsd EX-101.SCH 3033
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE smmt-20210921_lab.xml EX-101.LAB 34915
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE smmt-20210921_pre.xml EX-101.PRE 22794
5 EXTRACTED XBRL INSTANCE DOCUMENT e620954_8k-summit_htm.xml XML 3663
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36866 | Film No.: 211266465
SIC: 2834 Pharmaceutical Preparations